Skip to main content

Advertisement for PG in Life Sciences at JNCASR

Post Graduate Degree in Life Science OR Graduate / Post Graduate Degree in associated fields. The ideal candidate should have experience in Cell culture and Imaging. Knowledge of NGS data analysis is an added advantage, but it is not a prerequisite.
RCB Invites application from Life Sciences, Biotechnology, Bioinformatics candidates
Post-graduate degree in Life Sciences, Biotechnology, Bioinformatics or equivalent with minimum 60% marks. Identification of lead molecules for development of novel therapeutic strategies against viruses.
Advertisement for PG in Biotechnology, Biochemistry at IIIM
M.Sc. in Biotechnology, Botany, Biochemistry from a recognized University or equivalent with two years post M.Sc research experience.
Openings for Biotechnology or Microbiology in BIRAC funded research project at IISER
Graduation in the Biotechnology or Microbiology discipline with a good academic track record. OR a postgraduate degree in Biotechnology / Microbiology shall also be considered
Opportunity for Life Sciences in Head and Neck Cancer research at DYPBBI
M.Sc. in Life Sciences or related disciplines with a minimum of 55% marks or equivalent CGPA. Qualified in NET and or GATE.
Interview for M.Pharm, B.Pharm, MSc in Production, QA, QC, Packing at Torrent Pharma
Exposure of analysis for Finished Products. Stability Samples and Raw Materials. Having Knowledge of Analytical Method Validation. Verification and Method Transfer. Having skill for data interpretation, troubleshooting.
New Phase 3 data show HYMPAVZI dramatically cuts bleeding episodes in hemophilia  A and B patients with inhibitors
Pfizer unveiled very encouraging topline results from its Phase 3 BASIS clinical trial (NCT03938792). The study examined once‑weekly, under‑skin injections of HYMPAVZI (marstacimab) in adolescents and adults (12 years+) living with hemophilia A or B complicated by inhibitors an antibody that can neutralize traditional factor replacement therapy.
European Commission Approves Vertex’s Next-Generation Cystic Fibrosis Therapy, ALYFTREK®
Vertex Pharmaceuticals has announced that the European Commission has approved its newest cystic fibrosis treatment, ALYFTREK a once-daily, triple-combination therapy made up of deutivacaftor, tezacaftor, and vanzacaftor.
Career for Pharma Candidates to Join Indian Air Force
Medical Assistant trade (For candidates with Diploma/ B.Sc in Pharmacy). Unmarried candidate should be born between 02 July 2002 and 02 July 2007 (both dates inclusive). Married candidate should be born between 02 July 2002 and 02 July 2005 (both dates inclusive). 
District Health Society looking for Pharmacists - 04 posts
D.Pharm, Integrated Pharmacy Course for certificates issued by Government of Tamilnadu only. Weight age from the date of completion of course. one mark for every completed year maximum of 10 marks.